Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.
OBJECTIVE: To assess the utility of circulating adhesion molecule levels as a prognostic indicator of disease progression in systemic sclerosis (SSc) patients with early onset disease. METHODS: Ninety-two Japanese patients with early onset SSc presenting with diffuse skin sclerosis and/or interstiti...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3916412?pdf=render |
id |
doaj-efb00b1987674d529350fb02fc1f72c2 |
---|---|
record_format |
Article |
spelling |
doaj-efb00b1987674d529350fb02fc1f72c22020-11-24T21:51:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8815010.1371/journal.pone.0088150Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study.Minoru HasegawaYoshihide AsanoHirahito EndoManabu FujimotoDaisuke GotoHironobu IhnKatsumi InoueOsamu IshikawaYasushi KawaguchiMasataka KuwanaFumihide OgawaHiroki TakahashiSumiaki TanakaShinichi SatoKazuhiko TakeharaOBJECTIVE: To assess the utility of circulating adhesion molecule levels as a prognostic indicator of disease progression in systemic sclerosis (SSc) patients with early onset disease. METHODS: Ninety-two Japanese patients with early onset SSc presenting with diffuse skin sclerosis and/or interstitial lung disease were registered in a multicentre, observational study. Concentrations of intercellular adhesion molecule (ICAM) -1, E-selectin, L-selectin, and P-selectin in serum samples from all patients were measured by enzyme-linked immunosorbent asssay (ELISA). In 39 patients, adhesion molecule levels were measured each year for four years. The ability of baseline adhesion molecule levels to predict subsequent progression and severity in clinical and laboratory features were evaluated statistically. RESULTS: At their first visit, serum levels of ICAM-1, E-selection, P-selectin were significantly elevated and serum L-selectin levels were significantly reduced in patients with SSc compared with healthy controls. Overall, serum ICAM-1 levels at each time point were significantly inversely associated with the %vital capacity (VC) of the same time and subsequent years by univariate analysis. The initial serum ICAM-1 levels were significantly inversely associated with the %VC at the fourth year by multiple regression analysis. The initial serum P-selectin levels were significantly associated with the health assessment questionnaire disability index (HAQ-DI) at the fourth year by multiple regression analysis. Initial adhesion molecule levels were not significantly associated with other clinical features including skin thickness score. Baseline adhesion molecule levels were not significantly associated with subsequent rate of change of clinical parameters. CONCLUSION: In patients with SSc, serum levels of ICAM-1 and P-selectin may serve as prognostic indicators of respiratory dysfunction and physical disability, respectively. Further longitudinal studies of larger populations are needed to confirm these findings.http://europepmc.org/articles/PMC3916412?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Minoru Hasegawa Yoshihide Asano Hirahito Endo Manabu Fujimoto Daisuke Goto Hironobu Ihn Katsumi Inoue Osamu Ishikawa Yasushi Kawaguchi Masataka Kuwana Fumihide Ogawa Hiroki Takahashi Sumiaki Tanaka Shinichi Sato Kazuhiko Takehara |
spellingShingle |
Minoru Hasegawa Yoshihide Asano Hirahito Endo Manabu Fujimoto Daisuke Goto Hironobu Ihn Katsumi Inoue Osamu Ishikawa Yasushi Kawaguchi Masataka Kuwana Fumihide Ogawa Hiroki Takahashi Sumiaki Tanaka Shinichi Sato Kazuhiko Takehara Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. PLoS ONE |
author_facet |
Minoru Hasegawa Yoshihide Asano Hirahito Endo Manabu Fujimoto Daisuke Goto Hironobu Ihn Katsumi Inoue Osamu Ishikawa Yasushi Kawaguchi Masataka Kuwana Fumihide Ogawa Hiroki Takahashi Sumiaki Tanaka Shinichi Sato Kazuhiko Takehara |
author_sort |
Minoru Hasegawa |
title |
Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. |
title_short |
Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. |
title_full |
Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. |
title_fullStr |
Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. |
title_full_unstemmed |
Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. |
title_sort |
serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: a multicentre, prospective, observational study. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
OBJECTIVE: To assess the utility of circulating adhesion molecule levels as a prognostic indicator of disease progression in systemic sclerosis (SSc) patients with early onset disease. METHODS: Ninety-two Japanese patients with early onset SSc presenting with diffuse skin sclerosis and/or interstitial lung disease were registered in a multicentre, observational study. Concentrations of intercellular adhesion molecule (ICAM) -1, E-selectin, L-selectin, and P-selectin in serum samples from all patients were measured by enzyme-linked immunosorbent asssay (ELISA). In 39 patients, adhesion molecule levels were measured each year for four years. The ability of baseline adhesion molecule levels to predict subsequent progression and severity in clinical and laboratory features were evaluated statistically. RESULTS: At their first visit, serum levels of ICAM-1, E-selection, P-selectin were significantly elevated and serum L-selectin levels were significantly reduced in patients with SSc compared with healthy controls. Overall, serum ICAM-1 levels at each time point were significantly inversely associated with the %vital capacity (VC) of the same time and subsequent years by univariate analysis. The initial serum ICAM-1 levels were significantly inversely associated with the %VC at the fourth year by multiple regression analysis. The initial serum P-selectin levels were significantly associated with the health assessment questionnaire disability index (HAQ-DI) at the fourth year by multiple regression analysis. Initial adhesion molecule levels were not significantly associated with other clinical features including skin thickness score. Baseline adhesion molecule levels were not significantly associated with subsequent rate of change of clinical parameters. CONCLUSION: In patients with SSc, serum levels of ICAM-1 and P-selectin may serve as prognostic indicators of respiratory dysfunction and physical disability, respectively. Further longitudinal studies of larger populations are needed to confirm these findings. |
url |
http://europepmc.org/articles/PMC3916412?pdf=render |
work_keys_str_mv |
AT minoruhasegawa serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT yoshihideasano serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT hirahitoendo serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT manabufujimoto serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT daisukegoto serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT hironobuihn serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT katsumiinoue serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT osamuishikawa serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT yasushikawaguchi serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT masatakakuwana serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT fumihideogawa serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT hirokitakahashi serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT sumiakitanaka serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT shinichisato serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy AT kazuhikotakehara serumadhesionmoleculelevelsasprognosticmarkersinpatientswithearlysystemicsclerosisamulticentreprospectiveobservationalstudy |
_version_ |
1725880175310143488 |